Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nocera (NCRA) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Nocera (NCRA) over the last 9 years, with Q3 2025 value amounting to $2.0 million.

  • Nocera's Cash & Equivalents rose 44643.27% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 44643.27%. This contributed to the annual value of $484161.0 for FY2024, which is 6062.39% down from last year.
  • As of Q3 2025, Nocera's Cash & Equivalents stood at $2.0 million, which was up 44643.27% from $150130.0 recorded in Q2 2025.
  • Over the past 5 years, Nocera's Cash & Equivalents peaked at $2.9 million during Q4 2022, and registered a low of $150130.0 during Q2 2025.
  • Its 5-year average for Cash & Equivalents is $1.2 million, with a median of $1.1 million in 2023.
  • Over the last 5 years, Nocera's Cash & Equivalents had its largest YoY gain of 44643.27% in 2025, and its largest YoY loss of 7439.91% in 2025.
  • Quarter analysis of 5 years shows Nocera's Cash & Equivalents stood at $2.4 million in 2021, then increased by 18.91% to $2.9 million in 2022, then plummeted by 57.69% to $1.2 million in 2023, then tumbled by 60.62% to $484161.0 in 2024, then soared by 320.15% to $2.0 million in 2025.
  • Its Cash & Equivalents was $2.0 million in Q3 2025, compared to $150130.0 in Q2 2025 and $531771.0 in Q1 2025.